• Submitted by: manso
• Business and Economy
• 09 / 18 / 2010

---

HAVANA (AFP) – Cuba signed an agreement with Syria Friday to sell the Arab country anti-cancer drugs, vaccines and technology for producing human placenta derivatives, the Cuban press said Friday.

The official Communist Party newspaper Granma said the agreements anticipate the creation in Syria of a center "for the production of human placenta derivatives."

Monoclonal antibodies, an unidentified vaccine and drugs to suppress the growth of cancer tumors also were registered for sale in Syria, the newspaper said.

The agreements were signed by Syrian Health Minister, Rida Adnan, and Cuba's Science, Technology and Environment Minister Jose Miyar Barruecos.

Research into the use of human placenta in the medical world has increased in recent years, with scientists identifying placenta-based stem cells that could be used in therapy in which the regenerative cells are introduced into damaged tissue to treat disease or injury.

Source: http://news.yahoo.com/s/afp/20100917/wl_mideast_afp/cubasyriahealthpharm...